Bone morphogenetic proteins (BMPs) 2 were originally identified as an activity inducing ectopic bone formation when implanted into muscle tissue (1) . Isolation of BMPs using heparin affinity column chromatography and molecular cloning of BMPs revealed that the ectopic bone-inducing activity is due to several BMPs (2, 3) . More than 15 BMPs have since been identified in vertebrates and are classified into several subgroups: the BMP-2/4 subgroup, the BMP-5/6/7/8 subgroup, the GDF (growth and differentiation factor)-5 (also termed BMP-14)/ GDF-6 (BMP-13)/GDF-7 (BMP-12) subgroup, and the BMP-3 subgroup (4 -6) . With the exception of BMP-1, BMPs are members of the TGF-␤ superfamily, which includes multifunctional factors in vertebrates and invertebrates (3) . BMPs play critical roles in skeletal development, especially in mammals (4 -7) .
BMPs regulate the differentiation and function of cells that are involved in bone and cartilage formation and deformation, including osteoblasts, chondrocytes, and osteoclasts (4, 5, 7) . A cell culture system using C2C12 myoblasts can mimic part of the process of the ectopic bone formation induced by BMPs in muscle tissue (8) . BMPs inhibit myogenic differentiation of myoblasts into mature muscle cells and convert their differentiation pathway into that of osteoblast lineage cells. Using this model system in vitro, a critical factor for osteoblast differentiation (termed Osterix) has been cloned as a novel zinc finger transcription factor induced by BMP-2 (9) . Osterix knock-out mice do not have bone tissues because of lack of osteoblast differentiation from mesenchymal progenitor cells (9) . Although several growth factors, including TGF-␤ and activin, inhibit the myogenic differentiation of C2C12 cells in vitro, they do not induce osteoblast differentiation (8, 10) . It has been reported that TGF-␤ itself fails to induce ectopic bone formation in vivo (2) . These findings suggest that the C2C12 cell model system is useful for examining the molecular mechanisms of TGF-␤ superfamily members during ectopic bone formation in muscle tissue. It should therefore be useful for examining the molecular mechanism of bone formation and osteoblast differentiation induced by BMPs.
BMP signaling is transduced by two types of transmembrane serine/threonine kinase receptors. BMP receptors IA (ALK-3) and IB (ALK-6), ALK-1, and ALK-2 function as type I BMP receptors, whereas BMP receptor II and activin receptors II and IIB function as type II receptors, which are constitutively active kinases (4, (11) (12) (13) . After type II receptors phosphorylate type I receptors in a ligand-dependent fashion, activated type I receptors phosphorylate downstream molecules in the cytoplasm. The Smad1/5/8 transcription factors are phosphorylated by BMP type I receptors in the cytoplasm as substrates and accumulate in the nucleus within 1 h after BMP stimulation (4, (11) (12) (13) . The phosphorylated Smad proteins directly regulate expression of primary target genes through binding to their promoter or enhancer elements together with Smad4 and other transcription factors (14, 15) .
BMP activity is positively and negatively regulated by many types of molecules both intracellularly and in the extracellular environment (7, 13, 16) . Various corepressors and coactivators of Smad proteins have been identified in the cytoplasm or nucleus in mammalian cells. Noggin, chordin, follistatin, and the DAN family proteins bind to BMPs in the extracellular space and inhibit binding of ligands to cellsurface receptors (16) . In contrast, heparin enhances BMPinduced osteoblast differentiation in C2C12 myoblasts in vitro (17) . Other types of sulfated polysaccharides such as native heparan sulfate and synthetic dextran sulfate also stimulate BMP-2 (17) . The capacity of these sulfated polysaccharides to stimulate BMP-2 appears to depend on the size and number of their sulfated residues (17) . Heparin does not enhance osteoblast differentiation induced by direct activation of the BMP intracellular signaling pathway by overexpression of a constitutively active BMP receptor without addition of BMPs (17) . This finding suggests that heparin primarily exhibits effects upstream of the BMP receptor, including BMP ligands, rather than on the BMP intracellular signaling pathway. Heparin has been reported to enhance the activities of fibroblast growth factors by increasing the affinity of ligands for receptors as a coreceptor (18, 19) . However, heparin decreases the amount of BMP-2⅐receptor complex in C2C12 cells, suggesting that a novel mechanism of the heparin activity is involved in the case of BMPs (17) .
The unique and specific capacity of BMPs to induce new bone formation in vivo should be useful for the development of therapeutic drugs for in vivo bone regeneration (1, 20) . However, it has been reported that Ͼ100-fold larger amounts of BMPs are required to induce bone formation in higher animals such as monkeys and humans than in rodents (21) . We speculated that simultaneous administration of BMPs with sulfated polysaccharides might reduce the amounts of BMPs required to induce clinically useful amounts of new bone in vivo. In this study, we found that heparin stimulates the ectopic bone-forming activity of BMP-2 in vivo and propose a novel mechanism of the effects of heparin on BMP signaling in target cells.
MATERIALS AND METHODS
Recombinant Proteins and Heparin-Purified recombinant human BMP-2 was obtained from Astellas Pharmaceuticals Co., Ltd. (Tokyo, Japan). Recombinant human BMP-4 and BMP-6 and recombinant mouse noggin/Fc chimera were purchased from R&D Systems (Minneapolis, MN). Heparin prepared from porcine intestine and low molecular weight heparin was purchased from Sigma. Purified heparin for injection into patients was obtained from Fuso Pharmaceutical Industries, Ltd. (Osaka, Japan).
Cell Cultures-C2C12 myoblasts were maintained and treated with BMPs as described (8, 17) . Briefly, cells were inoculated at a density of 4.5 ϫ 10 4 cells/cm 2 1 day before treatment. The cells were treated with BMPs in the presence or absence of heparin in Dulbecco's modified Eagle's medium containing 2.5% fetal bovine serum. The concentrations of BMP-2 in the culture medium were quantified using an enzyme-linked immunosorbent assay kit (R&D Systems).
Alkaline Phosphatase Activity-Alkaline phosphatase (ALP) activity was measured as a marker of osteoblast differentiation (8) . Cells treated with an acetone/ethanol mixture (50:50, v/v) were incubated with a substrate solution composed of 0.1 M diethanolamine, 1 mM MgCl 2 , and 10 mg/ml p-nitrophenyl phosphate. The reaction was terminated by adding NaOH, and A values were measured at 405 nm. Reverse Transcription-PCR-The gene expression levels were determined by reverse transcription-PCR (22) . Total RNAs were extracted from C2C12 cells with TRIzol reagent (Invitrogen) and then reverse-transcribed using SuperScript II (Invitrogen). PCR amplification was performed with Platinum Pfx DNA polymerase (Invitrogen) and the following primers: ALP, GATCATTCCCACGTTTTCAC and TGCGGGCTTGTGG-GACCTGC; osteocalcin, CAAGTCCCACACAGCAGCTT and AAAGCCGAGCTGCCAGAGTT; Runx2 type I, ATGCGT-ATTCCTGTAGATCC and CTACAACCTTGAAGGCCACG; Runx2 types II and III, ATGCTTCATTCATTCGCCTCAC-AAAC and CCAAAAGAAGCTTTGCTG; Osterix, TTAAGCT-TGCGTCCTCTCTGCTTGA and TTTCTAGATCAGATCTC-TAGCAGGTT; noggin, ATGGAGCGCTGCCCCAGCCT and CTAGCAGGAACACTTACACT; and glyceraldehyde-3-phosphate dehydrogenase, TGAAGGTCGGTGTGAACGGAT-TGGC and CATGTAGGCCATGAGGTCCACCAC. cDNA was denatured at 94°C for 5 min, followed by 25 repeated cycles at 94°C for 45 s, annealing at 55°C for 1 min, and extension at 68°C for 1 min.
Histochemical Analysis-To determine protein levels immunohistochemically, cells were incubated with appropriate primary and secondary antibodies as described (8) . The following primary antibodies were used: anti-heparan sulfate clone F58-10E4 (Seikagaku Corp., Tokyo), anti-phosphorylated Smad1/5/8 (Cell Signaling Technology, Inc., Beverly, MA), and anti-myosin heavy chain clone MF-20 (Developmental Studies Hybridoma Bank, Iowa City, IA). To determine ALP activity histochemically, cells were stained for enzyme activity as described (8) . Staining was visualized with a BX50 fluorescence microscope with a DP50 digital CCD camera (Olympus Corp., Tokyo).
Western Blot Analysis-C2C12 cells were treated with 100 ng/ml BMP-2 in the presence or absence of 5 g/ml heparin and then lysed in Trisbuffered saline (25 mM Tris-HCl and 150 mM NaCl, pH 7.5) containing 1% Triton X-100 and 1ϫ protease inhibitor mixture (Roche Diagnostics) as described (17, 23) . The lysates were subjected to 8% SDS-PAGE and transferred to Immobilon-P membranes (Millipore Corp., Bedford, MA). Phosphorylated and total Smad1/5/8 proteins were detected using anti-phosphorylated Smad1/ 5/8 antibody and anti-Smad1 antibody (Upstate, Lake Placid, NY), respectively.
Determination of the Amounts of BMP-2-C2C12 cells were incubated for up to 50 h with 100 ng/ml BMP-2 in Dulbecco's modified Eagle's medium containing 2.5% fetal bovine serum. At each time point, the culture medium and cell lysate, which were prepared by extracting the cells with phosphate-buffered saline containing 1 M urea for 30 min at room temperature, were obtained and kept at Ϫ80°C until used. The amounts of BMP-2 in the culture medium and cell lysates were determined using the enzyme-linked immunosorbent assay kit according to the manufacturer's instructions.
Ectopic Bone Formation Assay-The effects of heparin on bone formation in vivo induced by BMP-2 were examined by ectopic bone formation assay in mice (24) . Five g of BMP-2 and 0, 0.25, 2.5, or 25 g of heparin were mixed and added to 20 ml of 0.01 M HCl solution; blotted onto a collagen sponge disk (6-mm diameter, 1-mm thickness) fabricated from commercially available bovine collagen sheets (Helistat, Integra NeuroSciences, Plainsboro, NJ); freeze-dried; and kept at Ϫ20°C until implanted into mice. All procedures were carried out under sterile conditions. Twenty-four male ICR mice (4-week-old; Nippon SLC, Hamamatsu, Japan) were housed and acclimated in cages with free access to food and water for 1 week, and they were divided into four groups (eight mice/group). The mice were anesthetized by diethyl ether gas inhalation, and the collagen pellets prepared as described above were surgically implanted into both dorsal muscle pouches (two pellets/ani-FIGURE 2. Effects of endogenous and exogenous sulfated polysaccharides on the ALP activity induced by BMP-2. A, C2C12 cells were treated with heparitinase at 0.001 or 0.01 unit/ml for 3 days in the presence of 300 ng/ml BMP-2. After 3 days of incubation, the cells were stained with anti-heparan sulfate antibody (HS; upper panels) or for ALP activity (lower panels). B, C2C12 cells were incubated for 3 days with graded concentrations of BMP-2 in the presence (F) or absence (E) of 0.1 unit/ml heparitinase, and ALP activity was then determined. C, ALP activity was determined in C2C12 cells cultured in the presence and absence of BMP-2 and/or heparin. C2C12 cells were inoculated 2 days before (Day Ϫ2) treatment with BMP-2 and/or heparin. The cells were treated without (Control) or with 100 ng/ml BMP-2 or 5 g/ml heparin on Day 0. A portion of the cultures were precultured with 5 g/ml heparin on Day Ϫ1 and then incubated with 100 ng/ml BMP-2 in the absence of heparin on Day 0 (Heparin Ͼ BMP2). In other cultures, on Day 0, the cells were treated with mixtures of 100 ng/ml BMP-2 and 5 g/ml heparin preincubated for 1, 3, 6, or 9 h at room temperature in a clean bench. The ALP activity in all of the cultures was determined on Day 3. mal) of the mice. At 2, 3, and 4 weeks after surgery, the mice were killed, and the implants were harvested and processed for histological analysis as follows. All harvested samples were radiographed with a soft x-ray apparatus (Sofron Co., Ltd., Tokyo). The bone mineral content (milligrams/ossicle) of each ossicle was measured by dual-energy x-ray absorptiometry using a bone mineral analyzer (DCS-600EX, ALOKA, Inc., Tokyo). Sections of the ossicles or tissue mass from each group were stained with hematoxylin/eosin and examined under a light microscope. Differences in bone mineral density among groups were evaluated by one-way analysis of variance To adjust for multiple comparisons when one-way analysis of variance showed a significant difference between groups ( p Ͻ 0.05), Fisher's least significant difference post hoc test was used to identify which group differences accounted for the significant p value. The analyses were conducted using StatView Version 5.0 (SAS Institute, Inc., Cary, NC).
RESULTS

Specificity of the Enhancing Effect of Heparin on Induction of
ALP Activity by BMPs-We first compared the effect of heparin on ALP activity, a typical marker of osteoblast differentiation, induced by BMP-2, BMP-4, and BMP-6 in C2C12 cells. As we reported previously (17) , heparin at 5 g/ml enhanced the ALP activity induced by both BMP-2 and BMP-4 (Fig. 1, A and B) . In contrast, the enzyme activity induced by BMP-6 was suppressed by heparin (Fig. 1C) . Drosophila DPP, a homolog of mammalian BMP-2 and BMP-4, failed to induce ALP activity in the presence or absence of heparin in our assay system (data not shown), although highly purified heparin had effects on BMP-2 similar to those of the heparin used throughout this study (Fig.  1D) . Low molecular weight heparin, which is ϳ5-fold smaller than native heparin, also enhanced induction of ALP activity by BMP-2, but to a lesser extent than native heparin (Fig. 1D) . The estimated ED 50 values of low molecular weight heparin and native heparin were 10 and 2 g/ml, respectively, suggesting that the size of sulfated polysaccharides is critical for enhancement of induction of ALP activity by BMPs.
Role of Endogenous Heparan Sulfate and Pretreatment with Heparin in Responses to
BMPs-C2C12 cells expressed heparan sulfate proteoglycans on the cell surface and/or in the extracellular space ( Fig. 2A, upper panels) . We next examined the role of endogenous heparan sulfate in responses to BMP-2. When C2C12 cells were pretreated with heparitinase and then further cultured with BMP-2 in the presence of heparitinase, endogenous heparan sulfate was removed from the cultures in a dosedependent manner ( Fig. 2A, upper panels) . However, similar numbers of ALP-positive cells were induced by BMP-2 regardless of the presence of heparitinase ( Fig. 2A, lower panels) . Furthermore, the dose dependence of the effects of BMP-2 on ALP activity was nearly equivalent in the presence and absence of 0.1 unit/ml heparitinase (Fig. 2B) .
We reported previously (17) that heparin does not enhance osteoblast differentiation induced by activation of a signaling pathway downstream of BMP receptors, suggesting that a primary target of heparin is upstream of the receptor. In agreement with this finding, pretreatment of C2C12 cells with hep- arin on Days Ϫ1 to 0 did not enhance the ALP activity induced by BMP-2 on Day 3 (Fig. 2C) . Moreover, preincubation of BMP-2 with heparin before treatment did not affect ALP activity (Fig. 2C) . Although we cannot rule out the possibility that the preincubation with heparin was negligible on Day 3, these results suggest that heparin rapidly modifies BMP-2 in culture medium.
Time Dependence of the Effects of Heparin on BMP-2 Activity-
We further examined the time courses of changes in the expression levels of genes related to osteoblast differentiation, such as ALP, osteocalcin, Osterix, and Runx2 type I and types II and III (Fig. 3) . The levels of Runx2 type I were not changed by BMP stimulation either with or without heparin until 48 h. Expression of the other genes was induced by BMP-2 and further stimulated by heparin after 24 h. However, the extent of induction of Osterix by BMP-2 at 4 h was not enhanced by heparin (Fig. 3) .
We next assessed whether heparin affects the levels of phosphorylation of Smad1/5/8 induced by BMP-2. BMP-2-induced phosphorylation of Smad1/5/8 peaked within 1 h and gradually decreased until 72 h (Fig. 4, A and B) . Interestingly, the phosphorylation levels of Smad proteins were not affected within 12 h by heparin, but were increased at 24 and 48 h (Fig. 4A ). This timedependent effect of heparin on the phosphorylation of Smad proteins was further confirmed by immunohistochemical analysis. Accumulation of phosphorylated Smad1/5/8 in nuclei was increased by BMP-2 stimulation at 24 h and thereafter only in the presence of heparin (Fig.  4B) . We further examined the time dependence of the enhancing effects of heparin on the phosphorylation of Smad proteins induced by BMP-2. C2C12 cells were stimulated with BMP-2 in the presence or absence of heparin for 1 or 24 h on Day 1 or 2 after cell inoculation to examine the effect of cell growth on the stimulatory capacity of heparin. Phosphorylated Smad proteins were increased only in cultures treated for 24 h with BMP-2 in the presence of heparin (Fig. 4C) , suggesting that the enhancement of Smad1/5/8 phosphorylation by heparin depends on the period of treatment and not the day of incubation. We examined the effect of heparin on the stability of phosphorylated Smad proteins. C2C12 cells were pretreated for 1 or 6 h with BMP-2 to induce Smad phosphorylation, cultured without BMP-2, and finally examined for the levels of phosphorylated Smad proteins at 24 h. Phosphorylated Smad proteins were undetectable in cultures pretreated with BMP-2 for 1 or 6 h even in the presence of heparin (Fig. 4D) , suggesting that heparin enhances the levels of phosphorylated Smad proteins induced by BMP-2 without increasing their stability.
Heparin Maintains the Concentration of BMP-2 in Culture Medium-Because phosphorylated Smad proteins were increased by heparin only in the presence of BMP-2, we determined the amounts of BMP-2 in the culture medium in the presence and absence of heparin. Surprisingly, in the absence of heparin, the concentration of BMP-2 in the culture medium rapidly decreased below 50% of the original concentration within 1 h and was almost undetectable after 10 h (Fig. 5A) . In contrast, in the presence of heparin, Ͼ60% of BMP-2 remained in the culture medium at 12 h, and BMP-2 was still detectable at 50 h (Fig. 5A) . We also determined the amounts of BMP-2 in cell layers throughout the culture period. As shown in Fig. 5A  (right panel) , the amounts of BMP-2 were Ͻ10% in the presence and absence of BMP-2, suggesting that the disappearance of BMP-2 from the culture medium is due to degradation of the ligand rather than accumulation in cell layers. We next examined whether BMP-2 in culture medium affects the differentiation of C2C12 cells in the absence of heparin. When C2C12 cells were treated for 3 days with graded concentrations of BMP-2, myogenic differentiation was almost completely inhibited by 100 ng/ml BMP-2, and osteoblast differentiation was induced by 300 ng/ml BMP-2 ( Fig. 5B) (8) . However, these concentrations were decreased to approximately one-third to one-tenth when the culture medium was changed every 24 h to keep the concentrations of BMP-2 in the medium (Fig. 5B) . These findings suggest that heparin blocks the rapid decrease in the BMP concentration in culture medium and that lower concentrations of BMP-2 are capable of affecting the pathway of differentiation of C2C12 cells if they are continuously stimulated by daily refreshment of ligand.
Heparin Protects BMP Activity from Inhibition by NogginNoggin, a BMP antagonist that blocks BMP signaling in the extracellular space, is induced by BMPs as an early-response gene (25) . Noggin mRNA was induced within 1 h after BMP-2 stimulation in C2C12 cells (Fig. 6A) . The level of induction of noggin mRNA by BMP-2 was not enhanced by heparin at 1 h, but was increased at 72 h (Fig.  6A) . Furthermore, exogenously added recombinant noggin dosedependently decreased the numbers of ALP-positive cells induced by 300 ng/ml BMP-2. In contrast, 100 ng/ml BMP-2 with 5 g/ml heparin induced similar ALP activity levels compared with 300 ng/ml BMP-2 alone. Under this condition, large numbers of ALP-positive cells remained even in the presence of 300 ng/ml exogenous noggin (Fig.  6B ). These data suggest that heparin protects BMPs from inhibition by noggin.
Heparin Stimulates the Ectopic Bone Formation Induced by BMP-2 in Vivo-Finally, we examined the enhancing effect of heparin on BMP-2 activity in vivo. BMP-2 induced ectopic bone formation within2weeksinmice.Heparindosedependently increased the size of new bone induced by BMP-2 for up to 4 weeks (Fig. 7, A and B) . Heparin alone preserved more bone tissue induced by BMP-2 after 4 weeks of incubation than did BMP-2 alone (data not shown). Bone mineral density was also increased by heparin in a dose-dependent fashion (Fig. 7C) . At 4 weeks, the insides of the bone pellets treated with BMP-2 alone were filled with bone marrow. In the presence of heparin, however, not only bone marrow but also a large amount of trabecular bone was observed in the pellets (Fig. 7D) .
DISCUSSION
Some groups, including our own, have reported independently that sulfated polysaccharides such as heparin, heparan sulfate, and dextran sulfate enhance the osteoblast differentiation induced by BMPs in vitro (17, 26) . In this study, we have demonstrated that heparin enhanced the bone formation induced by BMP-2 in vivo as well. In the presence of heparin, BMP-2 induced larger amounts of mineralized bone tissues within 2 weeks in mice. Moreover, we have demonstrated that low molecular weight heparin, which is smaller than native FIGURE 6. Heparin protects BMP-2 from the inhibitory activity of noggin. A, reverse transcription-PCR analysis of noggin mRNA induced by BMP-2 in C2C12 cells. Cells were treated with 100 ng/ml BMP-2 in the presence or absence of 5 g/ml heparin for up to 72 h. The expression levels of noggin mRNA were examined by reverse transcription-PCR. GAPDH, glyceraldehyde-3-phosphate dehydrogenase. B, heparin protects BMP-2 from the inhibitory activity of noggin. C2C12 cells were cultured with graded concentrations of recombinant mouse noggin/Fc chimera in the presence of 300 ng/ml BMP-2 alone or 100 ng/ml BMP-2 plus 5 g/ml heparin. ALP activity was stained on Day 3 as a marker of osteoblast differentiation. Similar results were obtained in three independent experiments. unfractionated heparin and is widely used clinically, also enhanced BMP-2 activity at least in vitro, although the specific activity of low molecular weight heparin in enhancing this effect was less than that of native heparin. This confirmed our previous finding that sulfated polysaccharides stimulate BMP activities in a size-dependent fashion (17) . Taken together, these findings suggest that simultaneous application of BMP-2 and sulfated polysaccharides is useful for regeneration of local bone tissues in vivo. This possibility requires examination in in vivo models of bone regeneration in higher animals.
Cultured cells express various types of proteoglycans, which consist of core proteins and polysaccharide chains, including heparan sulfate (27) (28) (29) . We have shown that not only heparin but also other types of sulfated polysaccharides such as native heparan sulfate and synthetic dextran sulfate enhance BMP activities (17) . These proteoglycans may accumulate on the cell surface and in the extracellular matrix and regulate BMP activities. Indeed, it has been reported that cell-surface proteoglycans inhibit the activity of BMP-7 in ROS17/2.8 osteosarcoma cells (30) . However, removal of heparan sulfate from cultures of C2C12 cells did not affect the osteoblast differentiation that occurred in response to BMP-2. This discrepancy in findings may due to differences in the cell types tested, i.e. osteosarcoma versus myoblasts, or in BMP subgroups, BMP-7 versus BMP-2. Interestingly, heparin inhibited the ALP activity that was stimulated by BMP-6 in C2C12 cells. BMP-6 is classified into the same subgroup as BMP-7 (but not BMP-2/4) based on amino acid similarity (31) . It appears that the positive or negative effects of sulfated polysaccharides on BMP activities depend on the primary structures of BMPs. Although all amino acid sequences of BMP-2-8 were identified in the bone-inducing fraction purified from bone extracts using a heparin column, the structures of the N termini of BMP-2 and BMP-4, which are thought to be the heparin-binding domains, are quite different from those of BMP-6 and BMP-7 (26, 31) . These differences may affect the three-dimensional structures and receptor-binding abilities of ligand⅐heparin complexes. Indeed, different types of receptors have been identified for the BMP-2 and BMP-7 subgroups (4, 5). These issues require further examination.
Heparin is thought to increase the binding affinity of fibroblast growth factor for its specific receptor and thereby enhance downstream signaling (18, 19) . A similar mechanism seems unlikely to occur in the case of BMPs because heparin does not stimulate complex formation between BMP-2 and the BMP type IA receptor on the surface of C2C12 cells (17) . Moreover, heparin failed to stimulate certain early events in response to BMP-2, such as the phosphorylation of Smad proteins and the induction of early-response genes, including noggin and osterix. Instead, heparin required Ͼ12 h to stimulate the events induced by BMP-2. Interestingly, we found that heparin maintained the concentration of BMP-2 in the culture medium at FIGURE 7. Heparin enhances the ectopic bone formation induced by BMP-2 in vivo. Five g of BMP-2 and 0, 0.25, 2.5, or 25 g of heparin were implanted subcutaneously to induce ectopic bone formation in mice as described under "Materials and Methods." After 2, 3, or 4 weeks (w), the implants were removed (A) and examined by soft x-ray analysis (B). The bone mineral density (BMD) of each implant was determined by dual-energy x-ray absorptiometry (C). Samples were analyzed by one-way analysis of variance. *, p Ͻ 0.05. Sections of the implants at 4 weeks were stained with hematoxylin/eosin (D).
higher levels and protected BMP-2 from inhibition by noggin, which was induced as part of the negative feedback loop in response to BMP-2. On the basis of the findings we obtained, we propose a novel mechanism for the stimulatory activity of heparin on BMPs (Fig. 8) . In the absence of heparin, BMP activities are negatively regulated by the inhibitory microenvironment, e.g. immediate decreases in the amounts of active ligands due to degradation, and BMP antagonists are induced by BMP signaling as part of the negative feedback loop to suppress excess signaling. However, in the presence of heparin, bioactive BMPs remain in the extracellular space for a longer period, and active ligands are protected from suppression by antagonists.
In conclusion, heparin stimulated not only the osteoblast differentiation induced by BMP-2 and BMP-4 in vitro but also the bone formation induced by BMP-2 in vivo. It appears that heparin stimulates BMP activities by protecting ligands from the inhibitory microenvironment around target cells rather than increasing receptor-binding affinity. These findings suggest that simultaneous administration of BMPs with sulfated polysaccharides should be clinically useful at least for local bone regeneration.
